Reliq Health Tech looks to raise up to $4-million
Reliq Health Technologies Inc. plans to sell up to 10 million units at 40 cents each for proceeds of $4-million. Part of the money will go to product development. Co-book runners in the offering are Canaccord Genuity and Gravitas Securities.
RELIQ HEALTH Technologies Inc. has entered into an engagement agreement with Canaccord Genuity Corp. and Gravitas Securities Inc. to act as co-lead agents on a commercially reasonable efforts basis in respect to a brokered private placement offering of up to 10 million units at a price of 40 cents per unit for gross proceeds of up to $4-million, subject to completion of satisfactory due diligence. Each unit will consist of one common share in the capital of the company and one-half transferable common share purchase warrant, with each warrant exercisable into one additional share at a price of 60 cents for a period of two years from the date of closing. The company intends to use the net proceeds of the offering for general working capital, product development and customer acquisition.
“We are delighted to have two of Canada’s leading independent brokerage firms support the company,” said Dr. Lisa Crossley, chief executive officer of Reliq. The company may pay fees and commissions on the offering within the amount permitted by the policies of the TSX Venture Exchange. Closing of the offering is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including the exchange. All securities issued in connection with the offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation.
For further information contact:
Core Capital Partners at 604-566-9233 or email@example.com.
We seek Safe Harbor.
Eugene Beukman, Lisa Crossley, Aman Thindal
(RHT) Shares: 84,072,638